NCT06294808View on ClinicalTrials.gov

Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC

CompletedOBSERVATIONAL
Enrollment

1,043

Participants

Timeline

Start Date

July 17, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hepatocellular Carcinoma Resectable
Trial Locations (2)

168583

National Cancer Centre, Singapore, Singapore

169608

Singapore General Hospital, Singapore

All Listed Sponsors
collaborator

Singapore General Hospital

OTHER

lead

National Cancer Centre, Singapore

OTHER

NCT06294808 - Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC | Biotech Hunter | Biotech Hunter